Interstitial fluid dynamics assessed by diffusion MRI may predict Aβ positivity conversion

Poster No:

189 

Submission Type:

Abstract Submission 

Authors:

Kaito Takabayashi1, Koji Kamagata1, Christina Andica1,2,3, Rui Zou1,2, Wataru Uchida3, Takafumi Kitagawa1,2, Sen Guo1, Junko Kikuta1, Akifumi Hagiwara1, Shigeki Aoki1,2,3

Institutions:

1Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan, 2Department of Data Science, Juntendo University Graduate School of Medicine, Tokyo, Japan, 3Faculty of Health Data Science, Juntendo University, Chiba, Japan

First Author:

Kaito Takabayashi  
Department of Radiology, Juntendo University Graduate School of Medicine
Tokyo, Japan

Co-Author(s):

Koji Kamagata  
Department of Radiology, Juntendo University Graduate School of Medicine
Tokyo, Japan
Christina Andica  
Department of Radiology, Juntendo University Graduate School of Medicine|Department of Data Science, Juntendo University Graduate School of Medicine|Faculty of Health Data Science, Juntendo University
Tokyo, Japan|Tokyo, Japan|Chiba, Japan
Rui Zou  
Department of Radiology, Juntendo University Graduate School of Medicine|Department of Data Science, Juntendo University Graduate School of Medicine
Tokyo, Japan|Tokyo, Japan
Wataru Uchida  
Faculty of Health Data Science, Juntendo University
Chiba, Japan
Takafumi Kitagawa  
Department of Radiology, Juntendo University Graduate School of Medicine|Department of Data Science, Juntendo University Graduate School of Medicine
Tokyo, Japan|Tokyo, Japan
Sen Guo  
Department of Radiology, Juntendo University Graduate School of Medicine
Tokyo, Japan
Junko Kikuta  
Department of Radiology, Juntendo University Graduate School of Medicine
Tokyo, Japan
Akifumi Hagiwara  
Department of Radiology, Juntendo University Graduate School of Medicine
Tokyo, Japan
Shigeki Aoki  
Department of Radiology, Juntendo University Graduate School of Medicine|Department of Data Science, Juntendo University Graduate School of Medicine|Faculty of Health Data Science, Juntendo University
Tokyo, Japan|Tokyo, Japan|Chiba, Japan

Introduction:

The accumulation of extracellular amyloid-β (Aβ), a pathologic hallmark of Alzheimer's disease (AD), begins more than 15 years before the onset of dementia (Sperling et al., 2013). Meanwhile, anti-amyloid therapies aimed at reducing Aβ accumulation and preventing cognitive decline have recently become widespread, but their therapeutic efficacy remains limited. This may be because interventions were implemented at a late stage of the disease. It may be clinically beneficial to identify patients with subthreshold Aβ levels that may change to Aβ (+) in the future and provide them with anti-amyloid therapy.
Recently, it has been suggested that abnormalities in brain interstitial fluid (ISF) dynamics are involved in Aβ accumulation. Estimation of the interstitial water content in the brain parenchyma, calculated as the volume fraction of free-water (FW) in a voxel with diffusion MRI, has become possible (Pasternak et al., 2009). It has also been reported that FW in white matter (WM) is associated with Aβ level in patients with AD (Kamagata et al., 2022). However, the association between ISF dynamics and Aβ accumulation in Aβ (−) healthy individuals remains poorly understood.
Therefore, the current study aimed to investigate whether FW can identify individuals who will convert to Aβ (+) and can predict future Aβ accumulation in Aβ (−) healthy individuals.

Methods:

The data used in this study were obtained from the Alzheimer's Disease Neuroimaging Initiative-GO, 2 cohort. We selected Aβ (−) cognitively normal subjects with baseline MRI scan and longitudinal 18F-florbetapir (AV45) PET scans with a total follow-up duration longer than 6.4 years. This cutoff for follow-up duration was defined based on the reported mean follow-up time for the transition from Aβ (−) to Aβ (+) (Jagust et al., 2021). Finally, we defined Aβ (−) subjects who converted to Aβ (+) within follow-up durations as converters and subjects who remained Aβ (−) as non-converters (Table 1). Amyloid positivity on AV45 PET was defined as above the global standardized uptake value ratio (SUVR) threshold of 1.11 (Landau et al., 2014).
Diffusion-weighted images (DWI; b-value = 1,000 s/mm2) were preprocessed with MRtrix3. FW map was estimated by preprocessed DWI to a bi-tensor model using the Freewater Estimator running Interpolated Initialization algorithm (Parker et al., 2020). Then, the mean cerebral FW (FW-WM) was calculated excluding WM lesions.
FW-WM was compared between groups using a general linear model while controlling for age, sex, years of education, APOE ε4 status, intracranial volume, scanning site, and follow-up duration. In addition, we applied multiple linear regression (MLR) to model the annual rate of change of global SUVR (dependent variable) and baseline FW-WM (independent variable), including the same covariates plus baseline global SUVR as covariates. A p-value <0.05 was considered statistically significant.
Supporting Image: Figure1.png
 

Results:

A total of 35 subjects were enrolled in the present study: 17 converters and 18 non-converters. There were no significant differences in age; sex; years of education; APOE ε4 carriers; follow-up durations; or baseline global SUVR between groups.
Compared with non-converters, the converters had significantly higher baseline FW-WM (p = 0.029, Cohen's d = 0.58; Figure 1A). In the MLR analysis, higher FW-WM was significantly associated with the higher annual rate of change of global SUVR (standardized β = 0.44, p = 0.025; Figure 1B).
Supporting Image: Figure2.png
 

Conclusions:

FW has been reported to correlate with brain clearance function measurements calculated by MRI with intrathecal contrast administration (Li et al., 2024), and elevated FW may indicate decreased Aβ efflux capacity due to abnormal ISF dynamics. Therefore, our findings suggest that evaluation of FW-WM might be useful for detecting Aβ converters and that abnormalities in ISF dynamics may be associated with the Aβ accumulation in Aβ (−) healthy individuals.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1

Novel Imaging Acquisition Methods:

Diffusion MRI 2

Keywords:

MRI
WHITE MATTER IMAGING - DTI, HARDI, DSI, ETC
Other - Interstitial fluid dynamics

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I am submitting this abstract as an original work to be reproduced. I am available to be the “source party” in an upcoming team and consent to have this work listed on the OSSIG website. I agree to be contacted by OSSIG regarding the challenge and may share data used in this abstract with another team.

Please indicate below if your study was a "resting state" or "task-activation” study.

Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Patients

Was this research conducted in the United States?

No

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

Not applicable

Please indicate which methods were used in your research:

Diffusion MRI

For human MRI, what field strength scanner do you use?

3.0T

Which processing packages did you use for your study?

FSL
Free Surfer
Other, Please list  -   MRtrix3

Provide references using APA citation style.

Jagust, W. J (2021). Temporal Dynamics of beta-Amyloid Accumulation in Aging and Alzheimer Disease. Neurology, 96(9), e1347-e1357.
Kamagata, K (2022). Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease. Neurology, 99(24), e2648-e2660.
Landau, S. M (2014). Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging, 41(7), 1398-1407.
Li, Y (2024). Novel functional network-level glymphatic clearance associated with network connectivity in human. OHBM2024 annual meeting.
Parker, D (2020). Freewater estimatoR using iNtErpolated iniTialization (FERNET): Characterizing peritumoral edema using clinically feasible diffusion MRI data. PLoS One, 15(5), e0233645.
Pasternak, O (2009). Free water elimination and mapping from diffusion MRI. Magn Reson Med, 62(3), 717-730.
Sperling, R. A (2013). Preclinical Alzheimer disease-the challenges ahead. Nat Rev Neurol, 9(1), 54-58.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No